ERBB3 and cancer: While previous studies have explored the mechanistic role of ASPN in other cancer-related pathways, including CD44 (37), TGF-β (34), and EGFR (79), to the best of our knowledge, our study is the first to report extracellular ASPN directly binds to HER3 and activates signaling through heterodimerization with HER2.